Brugada-like electrocardiographic pattern induced by lamotrigine toxicity
William J Strimel1, Amy Woodruff, Peter Cheung
1Section of Cardiac Electrophysiology and Pacing, Division of Cardiology, Scott and White Clinic, Department of Neurology, Scott and White Neuroscience Institute, Texas A&M University Health Science Center, Temple, TX, USA. wstrimel@swmail.sw.org
Toxic levels of lamotrigine, an epilepsy drug, can mimic Brugada syndrome by affecting cardiac sodium channels. This drug-induced Brugada ECG pattern may increase arrhythmia risk.
Area of Science:
- Cardiology
- Neurology
- Clinical Pharmacology
Background:
- Brugada syndrome is a genetic disorder affecting cardiac sodium channels, leading to sudden cardiac death.
- Certain medications can induce electrocardiographic (ECG) patterns mimicking Brugada syndrome.
Observation:
- A patient with epilepsy on lamotrigine presented with neurological symptoms and an ECG suggestive of Brugada pattern.
- Elevated serum lamotrigine levels were detected, prompting further investigation.
Findings:
- Lamotrigine, at toxic concentrations, demonstrated an effect on cardiac sodium channels, inducing a Brugada ECG pattern.
- This effect was reversible upon reduction of lamotrigine levels, with procainamide challenge becoming negative.
Implications:
- Clinicians must consider lamotrigine toxicity in patients presenting with Brugada ECG patterns, especially those with epilepsy.
- Toxic lamotrigine levels may pose a risk for ventricular dysrhythmias, necessitating careful monitoring.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
09:32Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
